Shockwave Medical to Report Second Quarter 2020 Financial Results on August 11, 2020
July 21 2020 - 4:05PM
Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the
development and commercialization of Intravascular Lithotripsy
(IVL) to treat complex calcified cardiovascular disease, today
announced it will report financial results for the second quarter
2020 after market close on Tuesday, August 11, 2020. Company
management will host a corresponding teleconference that will be
webcasted live beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time.
Investors interested in listening to the conference call may do
so by dialing (866) 795-9106 for domestic callers or (470) 495-9173
for international callers, using conference ID: 8889064. A live and
archived webcast of the event will be available at
https://ir.shockwavemedical.com.
About Shockwave Medical, Inc. Shockwave Medical
is focused on developing and commercializing products intended to
transform the way calcified cardiovascular disease is treated. The
company aims to establish a new standard of care for the
interventional treatment of atherosclerotic cardiovascular disease
through differentiated and proprietary local delivery of sonic
pressure waves for the treatment of calcified plaque, which the
company refers to as Intravascular Lithotripsy (IVL). IVL is a
minimally invasive, easy-to-use and safe way to significantly
improve patient outcomes. To view an animation of the IVL procedure
and for more information, visit www.shockwavemedical.com.
Media Contact:Scott
Shadiow+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie
Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Shockwave Medical (NASDAQ:SWAV)
Historical Stock Chart
From Sep 2023 to Sep 2024